Intracellularly retained V2 vasopressin receptor mutants activate different UPR signalling pathways.

被引：0
|
作者：
Lautz, K.
Grantcharova, E.
Schwieger, I.
Rosenthal, W.
Wiesner, B.
Huebner, N.
Hermosilla, R.
机构：
[1] Charite Univ Med Berlin, Inst Pharmakol, D-14195 Berlin, Germany
[2] Leibniz Inst Mol Pharmakol, D-13125 Berlin, Germany
[3] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2007年 / 375卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
30
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [1] Coupling between V1a and V2 vasopressin receptor transduction pathways.
    Klingler, C
    Barrault, MB
    Ancellin, N
    Morel, A
    Corman, B
    Friedlander, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0103 - A0103
  • [2] NDI causing vasopressin V2 receptor mutants: Retention mechanisms in the early secretory pathway and degradation pathways.
    Hermosilla, R
    Wiesner, B
    Rosenthal, W
    Schulein, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 542A - 542A
  • [3] Degradation of V2 vasopressin receptor mutants
    Schwieger, I
    Lautz, K
    Wiesner, B
    Hermosilla, R
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 33 - 33
  • [4] Rescue of vasopressin V2 receptor mutants by chemical chaperones: Specificity and mechanism
    Robben, JH
    Sze, M
    Knoers, NAM
    Deen, PMT
    MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (01) : 379 - 386
  • [5] Vasopressin V2 receptor antagonists
    Wong, LL
    Verbalis, JG
    CARDIOVASCULAR RESEARCH, 2001, 51 (03) : 391 - 402
  • [6] V2 vasopressin receptor mutations
    Makita, Noriko
    Manaka, Katsunori
    Sato, Junichiro
    Iiri, Taroh
    VASOPRESSIN, 2020, 113 : 79 - 99
  • [7] Phosphorylation of the V2 vasopressin receptor
    Innamorati, G
    Sadeghi, H
    Eberle, AN
    Birnbaumer, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (04) : 2486 - 2492
  • [8] Vasopressin V2 receptor antagonists
    Verbalis, JG
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2002, 29 (01) : 1 - 9
  • [9] Functional characterization of vasopressin V2 receptor mutants with defects in AVP-binding
    Bohnekamp, B
    Wiesner, B
    Schülein, R
    Hermosilla, R
    Rosenthal, W
    Oksche, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 36 - 37
  • [10] Vasopressin V2 Receptor/Bioligand Interactions
    Cezary Czaplewski
    Rajmund Kaźmierkiewicz
    Jerzy Ciarkowski
    Letters in Peptide Science, 1998, 5 : 333 - 335
12345